Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
暂无分享,去创建一个
H. Mo | P. Pang | J. McHutchison | E. Lawitz | F. Membreno | R. Hyland | F. Poordad | W. Symonds | Xiao Ding